Key points
University of Missouri researchers developed an AI tool named MeLSI to analyze gut microbiome data.
MeLSI identifies specific microbes driving biological changes, outperforming standard analytical methods.
The tool could help scientists detect diseases earlier and develop targeted medical interventions.
University of Missouri researchers are using artificial intelligence to uncover hidden clues among the trillions of bacteria living in the human gut, including changes that could one day help scientists detect diseases earlier.
The Mizzou team — which brings together expertise in medicine, data science, and engineering — developed a new machine-learning tool capable of finding biological signals that conventional methods miss.
The tool, called Metric Learning for Statistical Inference, or MeLSI, cuts through the complexity of microbiome data to identify the microbes driving key biological changes. That insight matters because researchers increasingly believe microbiome changes can begin months or even years before symptoms appear.
“We’re starting to see that small changes in the gut microbiome may occur long before people begin to show symptoms of neurological diseases such as Alzheimer’s,” said Ai-Ling Lin, a professor of biological sciences in Mizzou’s College of Arts and Science, professor of radiology in the School of Medicine and a NextGen Precision Health investigator. “If we can identify those changes earlier, we could find ways to mitigate or even reverse them.”
Traditional analytical methods can reveal broad differences between healthy and diseased microbial communities. MeLSI goes a step further by identifying the specific microbes responsible for those changes, giving researchers a clearer picture of what’s changing within the microbiome.
“Standard approaches are like using a generic ruler to measure everything,” said Lead Author Nathan Bresette, Doctoral Student in Mizzou’s Institute for Data Science and Informatics. “Instead, MeLSI works more like a smart scanner that learns to ignore background clutter and focus on what matters most.”
When Mizzou researchers tested MeLSI using data from several previously published studies, the tool consistently revealed meaningful patterns that conventional methods missed.
In a study of more than 1,100 adults, MeLSI didn’t just confirm that men’s and women’s gut microbiomes differ. It pointed to the specific bacteria most responsible for that difference, giving researchers a concrete starting point for follow-up work. In a separate study comparing people on Western and high-fiber diets, MeLSI picked up a real dietary effect on the microbiome that standard methods missed.
Together, the findings demonstrate how the Mizzou-developed tool could give researchers a powerful new way to study how the microbiome influences health and disease, potentially leading to earlier detection and more targeted interventions.
Here is an exclusive Tech Briefs interview, edited for length and clarity, with Bresette.
Tech Briefs: What was the biggest technical challenge you faced while developing MeLSI?
Bresette: The biggest challenge was combining math, statistics, and machine learning into one method that could adapt to the microbiome community. Each field has its own way of thinking, and getting them to work together so the method learns from the data but still gives results people can trust took a lot of work.
Tech Briefs: What was the biggest challenge you faced while testing MeLSI?
Bresette: Making sure the patterns MeLSI found were real. Before using it on real studies, we tested it on simulated data where we already knew the right answer, including cases with no true difference at all, to check that it wasn’t finding patterns that weren’t there. Then we ran it on published datasets to see whether it held up on real microbiome data.
Tech Briefs: Do you have any set plans for further research or next steps?
Bresette: Yes, we have already started using MeLSI in our own lab at Mizzou to uncover microbiome differences between groups in our experiments. It’s also free and available to other researchers through Bioconductor, so we want to see how other labs use it and keep improving it based on what they find.
Tech Briefs: Do you have any advice for researchers aiming to bring their ideas to fruition?
Bresette: Focus on a problem worth solving, develop a meaningful solution, and rigorously test it before broader implementation. Also, put your work out there so other people can use it. They’ll find things you never would have thought about.
Tech Briefs: Is there anything else you’d like to add?
Bresette: One thing I’d emphasize is explainability. It’s not enough to know that two groups of people have different microbiomes. Researchers need to know which bacteria are driving that difference. Figuring out what is really happening in the microbiome is what will lead to new discoveries, and that’s what MeLSI is built to help with. I’m also very grateful to my co-authors and to Mizzou for their support.
